Copyright
©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3267-3274
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3267
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3267
Table 2 Mixed meal test
| Time (min) | BG (mmol/L) | Insulin (µIU/mL) | C-peptide (0.78-5.19 ng/mL) | 3 mo later C-peptide |
| 0 | 15.36 | 10.9 (2.5 to 9.4) | < 0.01 | < 0.01 |
| 60 | 25.89 | 6.6 (11.9 to 43.5) | < 0.01 | < 0.01 |
| 120 | 26.99 | 5.6 (8.7 to 29.7) | < 0.01 | < 0.01 |
- Citation: Gao MJ, Xu Y, Wang WB. Immune checkpoint inhibitor therapy-induced autoimmune polyendocrine syndrome type II and Crohn’s disease: A case report. World J Clin Cases 2023; 11(14): 3267-3274
- URL: https://www.wjgnet.com/2307-8960/full/v11/i14/3267.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i14.3267